(Q40433970)

20 September 2017

1 reference

title

The role of human immunodeficiency virus type 1 envelope glycoproteins in virus infection (English)

1 reference

20 September 2017

The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection (English)

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

31 May 2024

author name string

E. O. Freed

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7592573

31 May 2024

M. A. Martin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7592573

31 May 2024

language of work or name

English

0 references

publication date

1 October 1995

1 reference

20 September 2017

13 October 1995

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=7592573

full work available at URL

31 May 2024

https://doi.org/10.1074/jbc.270.41.23883

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7592573

https://api.elsevier.com/content/article/PII:S0021925818574603?httpAccept=text/xml

31 May 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

https://api.elsevier.com/content/article/PII:S0021925818574603?httpAccept=text/plain

31 May 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

https://syndication.highwire.org/content/doi/10.1074/jbc.270.41.23883

31 May 2024

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Journal of Biological Chemistry

31 May 2024

published in

1 reference

20 September 2017

270

1 reference

20 September 2017

41

1 reference

20 September 2017

23883-23886

1 reference

Genetic variability of the AIDS virus: nucleotide sequence analysis of two isolates from African patients

20 September 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Identification of conserved and divergent domains within the envelope gene of the acquired immunodeficiency syndrome retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Studies with crosslinking reagents on the oligomeric structure of the env glycoprotein of HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Oligomeric structure of the human immunodeficiency virus type 1 envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Site-directed mutations in sindbis virus E2 glycoprotein's cytoplasmic domain and the 6K protein lead to similar defects in virus assembly and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Three-dimensional structure of a membrane-containing virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes. An insight into virus assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Expanded HIV-1 cellular tropism by phenotypic mixing with murine endogenous retroviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

HIV infection is blocked in vitro by recombinant soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

A soluble form of CD4 (T4) protein inhibits AIDS virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Stimulation of glycoprotein gp120 dissociation from the envelope glycoprotein complex of human immunodeficiency virus type 1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the complementarity-determining region 3-like regio

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Dissociation of gp120 from HIV-1 virions induced by soluble CD4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Resistance of primary isolates of human immunodeficiency virus type 1 to neutralization by soluble CD4 is not due to lower affinity with the viral envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Enhancement of SIV infection with soluble receptor molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Envelope glycoprotein of HIV induces interference and cytolysis resistance in CD4+ cells: mechanism for persistence in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

A VIRUS IN CHICK EMBRYOS WHICH INDUCES RESISTANCE IN VITRO TO INFECTION WITH ROUS SARCOMA VIRUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

The structure and function of the hemagglutinin membrane glycoprotein of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Viral and cellular membrane fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Paramyxovirus fusion: a hypothesis for changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Low-pH induced conformational changes in viral fusion proteins: implications for the fusion mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Identification of the fusion peptide of primate immunodeficiency viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Characterization of the fusion domain of the human immunodeficiency virus type 1 envelope glycoprotein gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

A synthetic peptide inhibitor of human immunodeficiency virus replication: correlation between solution structure and viral inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Infectious mutants of HTLV-III with changes in the 3' region and markedly reduced cytopathic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Effects of cytoplasmic domain length on cell surface expression and syncytium-forming capacity of the simian immunodeficiency virus envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Identification of Conserved Residues in the Human Immunodeficiency Virus Type 1 Principal Neutralizing Determinant That Are Involved in Fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Human genes other than CD4 facilitate HIV-1 infection of murine cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

CD26 antigen and HIV fusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

HIV-1 tropism for mononuclear phagocytes can be determined by regions of gp120 outside the CD4-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Identification of a determinant within the human immunodeficiency virus 1 surface envelope glycoprotein critical for productive infection of primary monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Role of HIV-1 envelope V3 loop cleavage in cell tropism

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Synergistic interaction between ligands binding to the CD4 binding site and V3 domain of human immunodeficiency virus type I gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

21 January 2018

A chink in HIV's armour?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.270.41.23883

Expression of membrane-associated and secreted variants of gp160 of human immunodeficiency virus type 1 in vitro and in continuous cell lines

21 January 2018

6

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Folding, interaction with GRP78-BiP, assembly, and transport of the human immunodeficiency virus type 1 envelope protein

31 May 2024

10

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Role of N-linked glycans of envelope glycoproteins in infectivity of human immunodeficiency virus type 1.

31 May 2024

14

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

The role of envelope glycoprotein processing in murine leukemia virus infection

31 May 2024

16

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Bulletin de l'Institut Pasteur

31 May 2024

19

88

73

Freed

1990

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

A furin-defective cell line is able to process correctly the gp160 of human immunodeficiency virus type 1.

31 May 2024

22

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Human immunodeficiency virus pseudotypes with expanded cellular and species tropism

31 May 2024

30

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range

31 May 2024

31

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity

31 May 2024

32

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.

31 May 2024

36

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

31 May 2024

44

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen

31 May 2024

47

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates

31 May 2024

59

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Increase in soluble CD4 binding to and CD4-induced dissociation of gp120 from virions correlates with infectivity of human immunodeficiency virus type 1.

31 May 2024

60

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Physicochemical dissociation of CD4-mediated syncytium formation and shedding of human immunodeficiency virus type 1 gp120.

31 May 2024

63

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Alterations in T4 (CD4) protein and mRNA synthesis in cells infected with HIV

31 May 2024

65

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum

31 May 2024

71

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

31 May 2024

Membrane fusion

77

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Identification and characterization of fusion and processing domains of the human immunodeficiency virus type 2 envelope glycoprotein

31 May 2024

83

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Role of the fusogenic peptide sequence in syncytium induction and infectivity of human immunodeficiency virus type 2.

31 May 2024

84

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Effects of second-site mutations on dominant interference by a human immunodeficiency virus type 1 envelope glycoprotein mutant

31 May 2024

86

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity

31 May 2024

94

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells

31 May 2024

100

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope

31 May 2024

104

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1

31 May 2024

108

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity

31 May 2024

112

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody.

31 May 2024

113

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Both the V2 and V3 regions of the human immunodeficiency virus type 1 surface glycoprotein functionally interact with other envelope regions in syncytium formation.

31 May 2024

114

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Relation of phenotype evolution of HIV-1 to envelope V2 configuration

31 May 2024

115

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells

31 May 2024

118

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s)

31 May 2024

121

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

CD26 antigen and HIV fusion?

31 May 2024

125

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

CD26 antigen and HIV fusion?

31 May 2024

126

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

CD26 is not involved in infection of peripheral blood mononuclear cells by HIV-1

31 May 2024

127

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Factors involved in entry of the human immunodeficiency virus type 1 into permissive cells: lack of evidence of a role for CD26.

31 May 2024

128

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Proteinase-resistant factors in human erythrocyte membranes mediate CD4-dependent fusion with cells expressing human immunodeficiency virus type 1 envelope glycoproteins

31 May 2024

129

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population

31 May 2024

131

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo

31 May 2024

139

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability.

31 May 2024

142

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion?

31 May 2024

144

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Evidence for a functional interaction between the V1/V2 and C4 domains of human immunodeficiency virus type 1 envelope glycoprotein gp120.

31 May 2024

148

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop

31 May 2024

150

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region

31 May 2024

153

1 reference

https://api.crossref.org/works/10.1074/JBC.270.41.23883

31 May 2024

Identifiers

1 reference

20 September 2017

1 reference